Health Care/Hospital

Menarini Silicon Biosystems launches new breakthrough DEPArray™ PLUS image-based cell sorter to isolate rare cells with single cell precision

DEPArray™ PLUS – the new automated and versatile platform to investigate pre-selected rare cell populations from various samples with 100% purity, now enhanced with 9 fluorescent channels and remarkably improved user experience BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., May 27, 2021 /PRNewswire/ ...

2021-05-27 15:00 537

Menarini Silicon Biosystems launches new breakthrough DEPArray™ PLUS image-based cell sorter to isolate rare cells with single cell precision

DEPArray™ PLUS – the new automated and versatile platform to investigate pre-selected rare cell populations from various samples with 100% purity, now enhanced with 9 fluorescent channels and remarkably improved user experience BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., May 27, 2021 /PRNewswire/ ...

2021-05-27 15:00 722

Love Never Stops, Joining hands to care NMOSD patients across Asia and saying "NO" to relapse

BEIJING, May 27, 2021 /PRNewswire/ -- There is such a group of patients, who are at the golden age of their lives and should have been energetic students in the ivory tower, ladies braving the wind and waves in the workplace, or warm wives expecting at home … Their lives were full of hopes and dr...

2021-05-27 14:18 807

Cambridge Quantum Develops Algorithm to Accelerate Monte Carlo Integration on Quantum Computers

CAMBRIDGE, United Kingdom, May 27, 2021 /PRNewswire/ -- Cambridge Quantum Computing (CQC ) today announced the discovery of a new algorithm that accelerates quantumMonte Carlo integration - shortening the time to quantum advantage and confirming the critical impo...

2021-05-27 14:00 789

Foresee Pharmaceuticals Announces FDA Approval of CAMCEVI® for the Treatment of Advanced Prostate Cancer; Accord BioPharma to Head the U.S. Commercialization

TAIPEI, May 26, 2021 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO), ("Foresee") announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for CAMCEVI® 42 mg, a ready-to-use 6-month subcutaneous depot formulation of leuprolide mesylate, as a ...

2021-05-27 11:33 1189

Esco Lifesciences Closes a Record-Setting US$200M Series A Round Led by Vivo Capital and Novo Holdings

SINGAPORE, May 27, 2021 /PRNewswire/ -- Esco Lifesciences ("Esco", the "Company") announced today the close of an over-subscribedUS$200 million Series A and Crossover round. The financing was led by Vivo Capital and Novo Holdings A/S, with participation from new investors including China Investme...

2021-05-27 09:00 1023

Neteera makes annual CNBC Disruptor 50 list second year running

JERUSALEM, May 27, 2021 /PRNewswire/ -- Neteera , global leader in contactless vital signs sensing, has been named for the second year running to theCNBC Disruptor 50 , an annual list of private venture-backed companies transforming...

2021-05-27 09:00 856

Gannex Received China IND Approval of Its FXR Agonist ASC42 for NASH Indication

SHANGHAI, May 27, 2021 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D and commercialization of new drugs in the field of non-alcoholic steatohepatitis (NASH), today announces that China National Medical Products Administration (NMP...

2021-05-27 08:30 1276

WuXi Biologics and OncoC4 Establish Exclusive CDMO Partnership

SHANGHAI and ROCKVILLE, Md., May 27, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, and OncoC4, Inc., a privately-held, clinical-stage biopharmaceutical company, today announced that the companies have entered ...

2021-05-27 08:30 3100

Advanced Micro- and Nanofluidics to Revolutionize the Point-of-care Diagnostic Industry

With the COVID-19 outbreak rapidly decentralizing healthcare diagnostics, the use of microfluidics-based point-of-care diagnostic devices can provide higher accuracy, finds Frost & Sullivan SANTA CLARA, Calif., May 27, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis, Advanced Micro- and ...

2021-05-27 02:59 810

Inteleos Announces MedGlobal and Global Ultrasound Institute as MissionPOCUS Selection for 2021

ROCKVILLE, Md., May 26, 2021 /PRNewswire/ -- The Point-of-Care Ultrasound (POCUS) Certification Academy under Inteleos announced a pilot project with MedGlobal and the Global Ultrasound Institute as the selection of their MissionPOCUS™ project for 2021. As the fourth MissionPOCUS project since th...

2021-05-26 23:36 790

Boan Biotech Grants AstraZeneca Exclusive Rights to Promote Boyounuo(R) (Bevacizumab Injection) in Specific County Markets of China

SHANGHAI, May 26, 2021 /PRNewswire/ -- Luye Pharma Group announced today that its holding subsidiary, Boan Biotech, has signed an agreement with AstraZeneca China regarding the promotion rights to the anticancer drugBoyounuo®  (Bevacizumab Injection), under which the former will grant to the latte...

2021-05-26 23:03 15256

TransThera announces collaboration with Roche to evaluate TT-00420 as part of a novel combination to treat GI cancers in China

NANJING, China, May 26, 2021 /PRNewswire/ -- TransThera Biosciences Co. Ltd. ( "TransThera" ), a clinical stage biotechnology company dedicated to developing innovative therapeutics across oncology, cardiovascular, and inflammatory diseases with major unmet medical needs globally and inChina,  to...

2021-05-26 21:00 632

Gracell Biotechnologies Hosting Key Opinion Leader Webinar on High Risk Multiple Myeloma, Treatment Challenges and Dual-Targeting CAR-T with Overnight Manufacturing - a Novel Approach for Treatment of Multiple Myeloma

SUZHOU, China and PALO ALTO, Calif., May 26, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, today ...

2021-05-26 21:00 9330

IT Tech Packaging, Inc. Officially Obtains FDA Approval for Surgical Mask Products

BAODING, China, May 26, 2021 /PRNewswire/ -- IT Tech Packaging, Inc. (NYSE AMERICAN: ITP) ("IT Tech Packaging" or the "Company"), a leading manufacturer and distributor of diversified paper products inNorth China, today announced that the Company has officially obtained approval for surgical mask...

2021-05-26 20:00 13328

Merck Accelerates Scale Up of Lipids to Meet Covid-19 Demand

- Introduces new synthetic cholesterol product nine months ahead of schedule - Offers high purity, scalability, and consistent quality - One of a few companies that produces lipids in quantities needed to meet demand for mRNA therapeutics, including Pfizer-BioNTech Covid-19 Vaccine   DARMSTADT,...

2021-05-26 20:00 768

RedHill Biopharma Receives Allowances for U.S. Patent Applications Covering Opaganib and RHB-107 for COVID-19

The two patents protect opaganib and RHB-107 for the treatment of COVID-19 until at least 2041 once granted Enrollment in opaganib's global Phase 2/3 study in hospitalized patients with severe COVID-19 is almost 100% complete RHB-107's ongoing Phase 2/3 study is enrolling U.S. non-hospitalized p...

2021-05-26 19:12 7740

TIAN RUIXIANG Holdings Ltd Signs Insurance Brokerage Services Agreement for Cooperation in Cancer Prevention Insurance

BEIJING, May 26, 2021 /PRNewswire/ -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the "Company"), aChina-based insurance broker, announces today that it has been commissioned by Zhongkang Yiyang (Beijing) Health Technology Co., Ltd.("Zhongkang"), a company providing technology and health managemen...

2021-05-26 18:30 12758

Prosit Sole Biotechnology Initiates First-In-Human Clinical Trial of Novel Interferon Lambda Chimera in US

BALTIMORE, May 26, 2021 /PRNewswire/ -- Prosit Sole Biotechnology, a clinical-stage biotech company developing novel protein therapeutics, today announces that it has initiated the first-in-human ("FIH") Phase I clinical trial of PSP001 in US. PSP001 is a novel, long acting and potent interferon ...

2021-05-26 16:10 483

IntoCare Medical Completes Up to 100 million RMB Round D Financing, Doubling Down on Powered Stapling Industry

SUZHOU, China, May 26, 2021 /PRNewswire/ -- IntoCare Medical Technology (Suzhou) Co., Ltd. (hereinafter referred to as "IntoCare"), a global pioneer in Powered Surgical Staplers, today announced the completion of up to100 million RMB round D financing. Qiming Venture Partners led the investment w...

2021-05-26 12:20 1104
1 ... 9101112131415 ... 1007